| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 5,121,804 | 5,410,828 | 5,261,254 | | Cost of Revenue | 3,540,596 | 3,770,007 | 3,622,962 | | | Gross Profit | 1,581,208 | 1,640,821 | 1,638,292 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,251,524 | 1,250,089 | 1,201,673 | | Non Recurring | 12,796 | 10,387 | 12,897 | | Others | 173,557 | 172,210 | 170,338 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 143,331 | 208,135 | 253,384 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 7,135 | 5,789 | | Earnings Before Interest And Taxes | 143,331 | 215,270 | 259,173 | | Interest Expense | 2,344 |
-
| 4,252 | | Income Before Tax | 140,987 | 215,270 | 254,921 | | Income Tax Expense | 55,591 | 76,917 | 102,606 | | Minority Interest | 30 | (2,554) | (1,788) | | | | Net Income From Continuing Ops | 85,426 | 135,799 | 150,527 | | | Non-recurring Events | | Discontinued Operations | (9,506) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 75,920 | 135,799 | 150,527 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $75,920 | $135,799 | $150,527 |
|
0.29% Nasdaq 
Income Statement
